Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004606765 | SCV005100497 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-06-09 | criteria provided, single submitter | clinical testing | The p.D379Y variant (also known as c.1135G>T), located in coding exon 13 of the CDC73 gene, results from a G to T substitution at nucleotide position 1135. The aspartic acid at codon 379 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |